Zemaira Kit
Product Images NDC 0053-7203

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zemaira (NDC 0053-7203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zemaira 01)

An instructional illustration showing a kit setup for ZEMAIRA, Alpha-1-Proteinase Inhibitor Human plasma derivative. It includes a vial labeled 'PRODUCT,' a vial labeled 'WATER,' and an infusion device with a drip chamber and tubing, indicating preparation or administration steps.*

FDA Label Image

Figure 2 (Zemaira 02)

An instructional illustration showing the placement of a cup upside down over a vial labeled 'WATER'. An arrow indicates the direction to position the cup firmly onto the vial. The image is likely part of usage directions for the ZEMAIRA kit containing Alpha-1-Proteinase Inhibitor Human, manufactured by CSL Behring LLC.*

FDA Label Image

Figure 3 (Zemaira 03)

Illustration showing how to remove a cap from a vial labeled 'WATER.' The cap is shown above the vial with an upward arrow indicating it should be pulled off. This is likely part of instructions for preparing the ZEMAIRA kit containing alpha-1-proteinase inhibitor human.*

FDA Label Image

Figure 4 (Zemaira 04)

An instructional diagram showing the assembly of a ZEMAIRA kit for administration. It depicts a water vial connected to a filter device, with an arrow indicating the water is to be pushed through the filter into a product vial labeled 'PRODUCT.' This illustrates the reconstitution process of the plasma derivative kit.*

FDA Label Image

Figure 5 (Zemaira 05)

An instructional illustration showing two hands preparing a product vial labeled 'PRODUCT.' One hand holds the vial while the other hand removes a cap from a dropper or connector, indicating a step in medication preparation or administration.*

FDA Label Image

Principal Display Panel (1000 mg Vial Label)

Illustration showing a vial labeled 'PRODUCT' with a cap, indicating a rotational arrow around the vial's base. This suggests instructions for handling or mixing the product contained in the vial.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Zemaira Alpha1-Proteinase Inhibitor (Human) plasma derivative kit. The label indicates a single dose vial with diluent in the 1000 mg range strength. The product is for intravenous administration only and is labeled for prescription use only. It is manufactured by CSL Behring LLC. The label includes storage instructions, NDC 0053-7201-02, and branding elements in blue and red on a white background.*

FDA Label Image

Zemaira 08

Packaging label for ZEMAIRA, an Alpha-1-Proteinase Inhibitor (Human) plasma derivative kit by CSL Behring LLC. The label indicates a 4000 mg range dosage for one single dose vial with diluent. The design includes the proprietary and generic names, storage instructions, manufacturer details, and the NDC number 0053-7202-02.*

FDA Label Image

Zemaira 09

Packaging label for Zemaira 5000 mg range Alpha1-Proteinase Inhibitor (Human) Kit by CSL Behring LLC. The label states the product is a plasma derivative for intravenous administration only, including one single dose vial with diluent. The label displays the proprietary name Zemaira, active ingredient, dosage form Kit, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.